XPAND_HE2022
@XPAND_HE2022
Followers
50
Following
12
Media
30
Statuses
47
A multidisciplinary consortium aiming at providing with an innovative application of hematopoietic stem cell expansion for gene therapy (GA 101070950).
Joined November 2022
📖 Explore the latest work of Toni Cathomen’s team!.In a Perspective article published on Nature Communications he sheds light on underappreciated genomic alterations induced by CRISPR technologies. Read the full paper 👉
nature.com
Nature Communications - CRISPR technologies hold vast potential for therapeutic gene editing, however large structural variations often arise, posing an underappreciated safety concern. Here, the...
0
0
1
📖 Explore the latest discoveries of X-PAND researchers!.The team led by Raffaella Di Micco published on Cell Reports Medicine a study in which they uncover senescence as an unexpected hurdle of HDR-based gene editing. Read the full paper 👉
0
0
0
📢 New Report on Cell & Gene Therapy!.The @EU_EISMEA has published the EIC pathfinder portfolio report, outlining key achievements and future directions in this rapidly evolving field. Read the full report here 👇.
0
1
0
That’s a wrap on the third X-PAND consortium meeting! .🚀 Over two days, experts from 🇮🇹🇪🇸🇩🇪🇨🇭 united to strengthen #synergies, refine our #exploitation strategy, and review exciting results on #genediting and #genetherapy. Huge thanks to all!
0
0
2
🌍Celebrating Women in Science!🔬.On this International Day of Women and Girls in Science, a special thank to the amazing women in X-PAND @DiMiccoLab @PauFerrol @SuNAlakira Ana Rosa Lopez and all the incredible women involved who push the boundaries of knowledge every day.🚀
0
0
4
🌍On this #WorldCancerDay, the X-PAND team reaffirms its commitment to advancing innovative cancer treatments through cutting-edge gene therapy and hematopoietic stem cell engineering. 👉
0
0
1
🚀 The @EU_EISMEA published the EIC Tech Report!. It highlights 34 emerging technologies that could shape Europe's future, including breakthroughs in healthcare. 🌍As an EIC Pathfinder project, X-PAND is proud to be part of this innovation ecosystem!.
eic.ec.europa.eu
The report highlights 34 emerging technologies and breakthrough innovations that could shape the industries of tomorrow.
0
0
1
📖Explore the latest discoveries of Toni Cathomen’s Lab!. In collaboration with Reichenbach’s group, he published in Communication Biology a study advancing the safety and precision of gene editing technologies for clinical applications. 👉
nature.com
Communications Biology - Simultaneous editing of the NCF1 and its pseudogenes in p47phox-deficient chronic granulomatous disease is associated with homologous recombination and chromosomal...
0
0
0
A huge step for Fanconi Anemia patients worldwide!🌍.The FANCOLEN-1 trial (published in @TheLancet) shows success of autologous #GeneTherapy without conditioning! 🚀20+ years of work by X-PAND scientists: @PauFerrol, @SuNAlakira and @JuanBueren.
thelancet.com
These results show for the first time that haematopoietic gene therapy without genotoxic conditioning enables sustained engraftment and reversal of BMF progression in patients with Fanconi anaemia.
0
3
8
🚀 The #EIC Work Programme 2025 brings €1.4B (+€200M vs 2024) to boost deep-tech research & innovative start-ups!. At X-PAND, we’re advancing #StemCellExpansion & #GeneTherapy as part of this effort. 🔍Discover new opportunities here👇.. @EU_EISMEA.
ec.europa.eu
The European Innovation Council (EIC), part of the EU research and innovation programme Horizon Europe, will support European deep tech research and high-potential start-ups with €1.4 billion next...
0
0
1
🚀 Exciting news from @ESGCT 2024. 👏Thrilled to share that X-PAND partners @PauFerrol and #BernhardGentner have joined the Board of the ESGCT! .They join #ToniCathomen, making an amazing team to drive #genetherapy & #celltherapy forward. Discover X-PAND👉
0
1
4
It’s the last day of the @ESGCT Annual Meeting and we are pleased to have X-PAND participating. If you are also attending, we invite you to meet us and follow our presentations!. 👇 For more details check the Meeting Program:
0
0
1
It’s the third day of the @ESGCT Annual Meeting and we are pleased to have X-PAND participating. If you are also attending, we invite you to meet us and follow our presentations!. 👇 For more details check the Meeting Program:
0
0
0
It’s the second day of the @ESGCT Annual Meeting and we are pleased to have X-PAND participating. If you are also attending, we invite you to meet us and follow our presentations!. 👇 For more details check the Meeting Program:
0
0
0
🚀 Today is the kick off of the @ESGCT annual meeting in Rome and we are pleased to have X-PAND participating. If you are also attending, we invite you to meet us and follow our presentations!. 👇 Check the Meeting Program and the list below to find us
0
0
1
We are excited to see our project highlighted in the Nat Biotech paper on the @EUeic health biotech portfolio published by Iordanis (Danos) Arzimanoglou. Proud to contribute to advancing cell therapy manufacturing and gene delivery systems!.Read it here👇.
nature.com
Nature Biotechnology - The European Innovation Council aims to catalyze the formation and growth of science-based businesses in Europe through highly targeted initiatives, actively managed...
0
1
4
🚀 Today is the kick off of the @ASGCTherapy Annual Meeting and we are pleased to have X-PAND researchers featuring in 6 talks. If you are also attending, we invite you to meet us and follow our presentations!. 👉For more details check the Meeting Program:
0
1
1
📣 Are you attending the CRISPR Medicine Conference 2024?. Do not miss the talks of X-PAND leaders @NaldiniLab, @PauFerrol and Toni Cathomen. 👉 Have a look at the full CRISPRMED24 Program here
0
7
7
📢 SR-Tiget (X-PAND member) and @LimulaB . (@pat4cgt_eu member) team up to explore the potential of a novel bioreactor design for hematopoietic stem cell expansion. Thanks to all participants for the productive kick-off meeting in Milan!
0
0
0
📢The recording of the @EUeic #CellandGeneTherapy Symposium: is now accessible online on the EIC website. Watch the speeches delivered by X-PAND coordinator Bernhard Gentner and by our collaborators Luc Henry (@pat4cgt_eu) and @LucaGattinoni (T-FITNESS). 👉
0
1
1